Werneburg, Nathan W.

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB

Mott, J. L., Kurita, S., Cazanave, S. C., Bronk, S. F., Werneburg, N. W., & Fernandez‐Zapico, M. E. (2010) · Journal of Cellular Biochemistry

MicroRNA in disease regulationCancer-related molecular mechanisms research

Cited by 282

Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

Ibrahim, S. H., Hirsova, P., Tomita, K., Bronk, S. F., Werneburg, N. W., Harrison, S. A., Goodfellow, V. S., Malhi, H., & Gores, G. J. (2016) · Hepatology

Extracellular vesicles in diseaseLiver Disease Diagnosis and Treatment

Cited by 232

Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis

Kakisaka, K., Cazanave, S. C., Fingas, C. D., Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., Mott, J. L., & Gores, G. J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Drug-Induced Hepatotoxicity and ProtectionLiver Disease Diagnosis and Treatment

Cited by 222

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization

Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Cell death mechanisms and regulationAutophagy in Disease and Therapy

Cited by 174

YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity

Sugihara, T., Werneburg, N. W., Hernandez, M. C., Yang, L., Kabashima, A., Hirsova, P., Yohanathan, L., Sosa, C., Truty, M. J., Vasmatzis, G., et al. (2018) · Molecular Cancer Research

Hippo pathway signaling and YAP/TAZCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 110